ARTICLE | Company News
FDA approves Boehringer Ingelheim's Micardis
November 20, 2000 8:00 AM UTC
The FDA granted marketing approval for Micardis HCT telmisartan/hydrochlorothiazide, a combination angiotensin II receptor antagonist and diuretic developed by Boehringer Ingelheim (Ridgefield, Conn.)...